According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

Quantifying the Active Pharmaceutical Ingredient (API) in a finished product is critical to ensure that consumers obtain the correct dosage. Too little dosage may limit its effectiveness, and too much ...

ALBANY, New York, Jan. 19, 2015 /PRNewswire/ -- AMRI (AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

DUBLIN--(BUSINESS WIRE)--The "Global Active Pharmaceutical Ingredient Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

The protein therapeutics market totaled $63 billion in 2007 ($39 billion in the U.S. alone) and is expected to reach $87 billion by 2010, according to a report by Kalorama Information—“Protein ...

(MENAFN- GlobeNewsWire - Nasdaq) Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERINTM API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and ...